Skip to main content
IMUX
NASDAQ Life Sciences

Immunic's Vidofludimus Calcium Shows Favorable Safety, Disability Signals in Additional Phase 2 Data

Tom Rudovsky · Reported by Wiseek News
More coverage: Biotech Stocks · Healthcare
Sentiment info
Positive
Importance info
8
Price
$12.5
Mkt Cap
$190.701M
52W Low
$5.062
52W High
$15.1
52W Position info
147% above low
Off High info
17% below high
Rel. Volume info
1.3× avg
Market data snapshot near publication time

IMUX has more than doubled off its 52-week low of $5.062.

Summary

Immunic presented additional positive Phase 2 CALLIPER data for its drug candidate, vidofludimus calcium. The post-hoc analyses showed favorable safety, tolerability, and disability assessment signals, with consistent benefits over placebo for confirmed disability changes. Patient-reported outcomes also indicated no worsening in depression scores and higher perceived effectiveness. This news reinforces the positive efficacy and safety data previously announced on May 14th, further de-risking the drug's development pathway and strengthening its potential.

At the time of this announcement, IMUX was trading at $12.50 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $190.7M. The 52-week trading range was $5.06 to $15.10. This news item was assessed with positive market sentiment and an importance score of 8 out of 10. Source: Wiseek News.


Price Chart

Share this article

Copied!

IMUX - Latest Insights

IMUX
Nov 13, 2026, 7:12 AM EST
Filing Type: 10-Q
Importance Score:
7
Price at Filing: $7.71
Real-time Price: $7.03 info
Change: -$0.680 (-9%) info
Market Cap: $111.007M info
IMUX
Nov 05, 2026, 9:00 AM EST
Filing Type: 8-K
Importance Score:
7
Price at Filing: $8.20
Real-time Price: $7.03 info
Change: -$1.17 (-14%) info
Market Cap: $111.007M info
IMUX
Sep 09, 2026, 9:01 AM EDT
Filing Type: 8-K
Importance Score:
7
Price at Filing: $13.26
Real-time Price: $7.03 info
Change: -$6.23 (-47%) info
Market Cap: $111.007M info
IMUX
Aug 11, 2026, 7:05 AM EDT
Filing Type: 8-K
Importance Score:
8
Price at Filing: $14.10
Real-time Price: $7.03 info
Change: -$7.07 (-50%) info
Market Cap: $111.007M info
IMUX
Aug 11, 2026, 6:59 AM EDT
Filing Type: 10-Q
Importance Score:
7
Price at Filing: $14.10
Real-time Price: $7.03 info
Change: -$7.07 (-50%) info
Market Cap: $111.007M info